Biopharmaceutical research firm CytoCore has entered into a five-year agreement with Mundinter for the distribution of the SoftPap cervical cell collector in Portugal.
Subscribe to our email newsletter
Mundinter’s agreement calls for minimum sales of 300k units the first year, 600k units the second, 1.0mm units the third, 1.1mm the fourth and minimum of 1.2mm units in the fifth year.
Robert McCullough Jr., CEO of CytoCore, said: “We are very pleased with this agreement as it adds to our developing momentum as the company ramps up distribution and sales. We are encouraged by the response from our European distributors, and expect the European markets will play a major role for our SoftPap collector as CytoCore continues to expand our distribution networks.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.